Please select the option that best describes you:
If a patient had a grade 2 infusion reaction to initial dose of IV Rituximab, can you give subcutaneous Rituximab for cycle 2 or continue with IV Rituximab?
Answer from: Medical Oncologist at Academic Institution
I would likely continue IV rituximab until no more infusion reactions are observed before switching to SQ.
Sign in or Register to read more